{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "JPY", "marketState": "CLOSED", "regularMarketChangePercent": 1.8826134, "regularMarketPrice": 4600.0, "exchange": "JPX", "shortName": "DAIICHI SANKYO COMPANY LIMITED", "longName": "Daiichi Sankyo Company, Limited", "messageBoardId": "finmb_23697721", "exchangeTimezoneName": "Asia/Tokyo", "exchangeTimezoneShortName": "JST", "gmtOffSetMilliseconds": 32400000, "market": "jp_market", "esgPopulated": false, "regularMarketTime": 1683872101, "earningsTimestamp": 1682584200, "earningsTimestampStart": 1690430400, "earningsTimestampEnd": 1690776000, "trailingAnnualDividendRate": 30.0, "trailingPE": 148.29143, "trailingAnnualDividendYield": 0.006644518, "epsTrailingTwelveMonths": 31.02, "epsForward": 109.52, "epsCurrentYear": 74.58, "priceEpsCurrentYear": 61.678734, "sharesOutstanding": 1916790016, "bookValue": 754.092, "fiftyDayAverage": 4617.2, "fiftyDayAverageChange": -17.200195, "fiftyDayAverageChangePercent": -0.0037252435, "twoHundredDayAverage": 4323.955, "twoHundredDayAverageChange": 276.04492, "twoHundredDayAverageChangePercent": 0.06384084, "marketCap": 9117613686784, "forwardPE": 42.00146, "priceToBook": 6.1000514, "sourceInterval": 15, "exchangeDataDelayedBy": 20, "averageAnalystRating": "1.9 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 946944000000, "priceHint": 2, "regularMarketChange": 85.0, "regularMarketDayHigh": 4600.0, "regularMarketDayRange": "4505.0 - 4600.0", "regularMarketDayLow": 4505.0, "regularMarketVolume": 4996900, "regularMarketPreviousClose": 4515.0, "bid": 4595.0, "ask": 4600.0, "fullExchangeName": "Tokyo", "financialCurrency": "JPY", "regularMarketOpen": 4525.0, "averageDailyVolume3Month": 3729284, "averageDailyVolume10Day": 4268457, "fiftyTwoWeekLowChange": 1587.0, "fiftyTwoWeekLowChangePercent": 0.52671754, "fiftyTwoWeekRange": "3013.0 - 4918.0", "fiftyTwoWeekHighChange": -318.0, "fiftyTwoWeekHighChangePercent": -0.06466043, "fiftyTwoWeekLow": 3013.0, "fiftyTwoWeekHigh": 4918.0, "symbol": "4568.T"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "3-5-1, Nihonbashi-honcho", "address2": "Chuo-ku", "city": "Tokyo", "zip": "103-8426", "country": "Japan", "phone": "81 3 6225 1111", "website": "https://www.daiichisankyo.com", "industry": "Drug Manufacturers\u2014General", "industryDisp": "Drug Manufacturers\u2014General", "sector": "Healthcare", "longBusinessSummary": "Daiichi Sankyo Company, Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; and ferric carboxymaltose injection for treating anemia. It also provides edoxaban, an oral, once-daily, direct factor Xa inhibitor; esaxerenone and olmesartan medoxomil antihypertensive agents; NILEMDO, an oral treatment to help in lowering cholesterol; and Nustendi, a fixed-dose combination tablet of bempedoic acid and ezetimibe for reducing cholesterol. In addition, the company offers Canalia for the treatment of type 2 diabetes mellitus; Emgality for the treatment of migraine attacks; Pralia for the treatment of osteoporosis/inhibitor of the progression of bone erosion associated with rheumatoid arthritis; Ranmark for the treatment of bone complications caused by bone metastases from tumors; Tarlige for treating pain; Tenelia for the treatment of Type 2 diabetes mellitus; Venofer for the treatment of iron deficiency anemia; and Vimpat, an anti-epileptic agent. Further, it provides vaccines for influenza, measles/rubella infection, and mumps. The company was founded in 1899 and is headquartered in Tokyo, Japan.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Sunao  Manabe D.V.M., Ph.D.", "age": 68, "title": "Group CEO & Exec. Chairperson", "yearBorn": 1954, "fiscalYear": 2022, "totalPay": {"raw": 277000000, "fmt": "277M", "longFmt": "277,000,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Masahiko  Ohtsuki", "age": 63, "title": "Sr. Exec. Officer, Head of Global DX, Chief Digital Transformation Officer & Director", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 107000000, "fmt": "107M", "longFmt": "107,000,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Shoji  Hirashima", "age": 61, "title": "Sr. Exec. Officer, Head of Japan Bus. Unit & Director", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": {"raw": 109000000, "fmt": "109M", "longFmt": "109,000,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Hiroyuki  Okuzawa", "age": 60, "title": "Pres, COO & Representative Director", "yearBorn": 1962, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Koji  Ogawa", "title": "Exec. Officer, Head of Global Corp. Planning and Management & CFO", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Naoto  Tsukaguchi", "title": "Gen. Counsel, Corp. Officer, Head of Global Leg., IP, Global Compl. and Risk & VP of Leg. Aff. Dept.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Kentaro  Asakura", "title": "VP of Corp. Communications Department", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Marielle  Cohard-Radice M.D.", "title": "Global Head of Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Akio  Sakurai", "title": "Corp. Officer, Head of Sales and Marketing Div. & Japan Bus. Unit", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Takashi  Matsumoto", "title": "Exec. Officer, Head of Global HR & Chief HR Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 1, "boardRisk": 1, "compensationRisk": 2, "shareHolderRightsRisk": 2, "overallRisk": 1, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}